- Home
- DUO vs CLDI Comparison
DUO vs CLDI Comparison
Compare DUO & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- CLDI
- Stock Information
- Founded
- DUO 2011
- CLDI 2014
- Country
- DUO China
- CLDI United States
- Employees
- DUO N/A
- CLDI N/A
- Industry
- DUO Real Estate
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DUO Finance
- CLDI Health Care
- Exchange
- DUO Nasdaq
- CLDI Nasdaq
- Market Cap
- DUO 17.1M
- CLDI 18.1M
- IPO Year
- DUO 2019
- CLDI N/A
- Fundamental
- Price
- DUO $0.61
- CLDI $0.89
- Analyst Decision
- DUO
- CLDI Strong Buy
- Analyst Count
- DUO 0
- CLDI 3
- Target Price
- DUO N/A
- CLDI $16.67
- AVG Volume (30 Days)
- DUO 2.0M
- CLDI 1.2M
- Earning Date
- DUO 08-30-2024
- CLDI 03-14-2025
- Dividend Yield
- DUO N/A
- CLDI N/A
- EPS Growth
- DUO N/A
- CLDI N/A
- EPS
- DUO N/A
- CLDI N/A
- Revenue
- DUO $37,352,654.00
- CLDI N/A
- Revenue This Year
- DUO N/A
- CLDI N/A
- Revenue Next Year
- DUO N/A
- CLDI N/A
- P/E Ratio
- DUO N/A
- CLDI N/A
- Revenue Growth
- DUO 6.61
- CLDI N/A
- 52 Week Low
- DUO $0.32
- CLDI $0.73
- 52 Week High
- DUO $4.67
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- DUO 46.04
- CLDI 32.62
- Support Level
- DUO $0.53
- CLDI $0.83
- Resistance Level
- DUO $0.62
- CLDI $0.95
- Average True Range (ATR)
- DUO 0.05
- CLDI 0.12
- MACD
- DUO 0.00
- CLDI -0.03
- Stochastic Oscillator
- DUO 43.82
- CLDI 11.29
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.